JPS6391196A - Dephosphorization method for night soil treatment by using ultrafilter membrane - Google Patents

Dephosphorization method for night soil treatment by using ultrafilter membrane

Info

Publication number
JPS6391196A
JPS6391196A JP61236725A JP23672586A JPS6391196A JP S6391196 A JPS6391196 A JP S6391196A JP 61236725 A JP61236725 A JP 61236725A JP 23672586 A JP23672586 A JP 23672586A JP S6391196 A JPS6391196 A JP S6391196A
Authority
JP
Japan
Prior art keywords
biological reaction
dephosphorization
night soil
phosphorus
tank
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61236725A
Other languages
Japanese (ja)
Inventor
Hitoshi Yano
仁 矢野
Kazunori Suzuki
鈴木 一典
Kotaro Hama
浜 光太郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Petrochemical Industries Ltd
Mitsui Engineering and Shipbuilding Co Ltd
Original Assignee
Mitsui Petrochemical Industries Ltd
Mitsui Engineering and Shipbuilding Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Petrochemical Industries Ltd, Mitsui Engineering and Shipbuilding Co Ltd filed Critical Mitsui Petrochemical Industries Ltd
Priority to JP61236725A priority Critical patent/JPS6391196A/en
Publication of JPS6391196A publication Critical patent/JPS6391196A/en
Pending legal-status Critical Current

Links

Landscapes

  • Separation Using Semi-Permeable Membranes (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Treatment Of Biological Wastes In General (AREA)

Abstract

PURPOSE:To permit effective removal of phosphorus by putting night soil into a dephosphorization plant, adding a flocculating agent thereto and removing the flocculated solid from the night soil in such a manner that the contained phosphorus components necessary for a biological reaction treatment remain in the separated liquid. CONSTITUTION:The night soil is treated in a biological reaction tank 20 and is then subjected to solid-liquid sepn. by an ultrafilter membrane 22. Sludge is returned to the vessel 20 and is partly treated as excess sludge. Before the night soil is supplied to the vessel 20, the night soil is fed to the dephosphorization plant 7 where the flocculating agent (e.g., cationic high- polymer flocculating agent and ferric polysulfate) is added to the night soil by a flocculating agent adder 9 to flocculate and solidify the phosphorus components contained in the night soil. The separated water is then fed to the tank 20. As a result, the phosphorus is effectively removed without increasing the load of suspended matter on the ultrafilter membrane.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は限外濾過膜を用いたし尿処理における脱リン方
法に関し、詳しくは膜処理後の処理水中の含有リン成分
濃度を低減でき、かつ膜に対するSS(浮遊物質、以下
同じ)負荷を軽減できるし尿処理における脱リン方法に
関する。
[Detailed Description of the Invention] [Industrial Application Field] The present invention relates to a dephosphorization method in human urine treatment using an ultrafiltration membrane. The present invention relates to a dephosphorization method in human waste treatment that can reduce the SS (suspended solids) load on membranes.

[発明の背景] 近年、し尿の高度処理法として、生物処理と膜処理を組
合せた画期的プロセスが開発され、特に本発明者らが開
発したASMEX (商標)プロセス(特願昭59−2
87725号明細書参照)は、「厚生省指針外し尿処理
施設」として認定され、当業界で好成績をあげている。
[Background of the Invention] In recent years, an innovative process that combines biological treatment and membrane treatment has been developed as an advanced treatment method for human waste.
No. 87725) has been certified as a ``human waste treatment facility outside the guidelines of the Ministry of Health and Welfare,'' and has achieved good results in the industry.

しかるにASMEXプロセスに用いられる限外濾過膜(
以下、OF膜という)は無機性分子状の物質(P、 N
Ox 、 Ml(4−N等)を阻止することができず、
富栄養化の原因とも考えられる窒素(N)分やリン(P
)分の流出が問題となる。しかし、窒素分については生
物処理で100%近く除去できるので流出の問題は少な
い。これに対しリン分については生物処理で50%除去
が限界であるため流出の問題がある。
However, the ultrafiltration membrane used in the ASMEX process (
The OF film (hereinafter referred to as the OF film) is made of inorganic molecular substances (P, N
Unable to block Ox, Ml (4-N, etc.),
Nitrogen (N) and phosphorus (P), which are thought to be the cause of eutrophication,
) leakage becomes a problem. However, nearly 100% of the nitrogen content can be removed through biological treatment, so there are few problems with runoff. On the other hand, with regard to phosphorus, biological treatment has a limit of 50% removal, so there is a problem of leakage.

このため木発明者は、UF膜通過後の処理水を一般的な
脱リン法で処理する方法を検討した。−・般的な脱リン
法としては、■凝集沈降除去法、■アパタイト晶析法、
■選択的吸着剤による吸着除去法が考えられる。
For this reason, the inventors investigated a method of treating the treated water after passing through the UF membrane using a general dephosphorization method. −・General dephosphorization methods include ■ coagulation sedimentation removal method, ■ apatite crystallization method,
■An adsorption removal method using a selective adsorbent can be considered.

■の凝集沈降除去法は、凝集剤を用いてリンを凝沈汚泥
として固定化し、脱水・焼却処理する方法であり、■の
アパタイト晶析法は、石灰を排水中に添加してリン酸ヒ
ドロオキシアパタイトとして晶析させ、骨炭あるいはカ
キガラ等の炭酸カルシウムの充填塔を通過させリンを除
去する方法である。
The coagulation-sedimentation removal method (■) uses a flocculant to fix phosphorus as flocculated sludge, which is then dehydrated and incinerated. This is a method in which phosphorus is removed by crystallizing it as oxyapatite and passing it through a column packed with calcium carbonate such as bone char or persimmon shell.

しかし、この■及び■の方法は、UF膜によってSSが
完全に除去された処理水にSSを含有させることになり
好ましい方法とは言えない。これに対し、かかる欠点の
少ない■の吸着除去法は、吸着剤中のリンを苛性ソーダ
と反応させてリン酸ソーダとして苛性ソーダ液にして取
り出す方法で、吸着剤は酸性水で洗って活性化し、再利
用し、取り出されたリン酸ソーダ溶液は下記の二つの方
法により処理するものである。
However, these methods (1) and (2) cannot be said to be preferable methods because they cause SS to be contained in the treated water from which SS has been completely removed by the UF membrane. On the other hand, the adsorption removal method (2), which has fewer such drawbacks, is a method in which the phosphorus in the adsorbent is reacted with caustic soda and extracted as sodium phosphate, a caustic soda solution.The adsorbent is washed with acidic water to activate it and then recycled The sodium phosphate solution used and taken out is treated by the following two methods.

(a)一つの方法はリン酸ソーダに塩化第2鉄を添加し
てリン酸鉄の結晶とし、この結晶を脱水・焼却し、分離
水は主処理工程に戻し処理する方法である。
(a) One method is to add ferric chloride to sodium phosphate to form iron phosphate crystals, dehydrate and incinerate the crystals, and return the separated water to the main treatment process.

(b)他の方法はリン酸ソーダ液に苛性ソーダを添加し
、溶解度差によって析出したリン酸ソーダの結晶を脱液
分離し、リン酸ソーダの結晶体として取り出し、分離水
は吸着剤の再生液として再使用する方法である。
(b) Another method is to add caustic soda to a sodium phosphate solution, remove the liquid and separate the sodium phosphate crystals that precipitate due to the solubility difference, and extract them as sodium phosphate crystals, and the separated water is used as the regenerated adsorbent solution. This is a method of reusing it as

しかし、上記■の方法は、設備コストやランニングコス
ト(アルカリ消費量等)が大きく、またプロセス管理も
困難であるという欠点がある。
However, method (2) above has the drawbacks of high equipment costs and running costs (alkali consumption, etc.) and difficult process control.

そこで上記の欠点を解決するために、UF膜を通過する
前に脱リンを図る方法が試みられている。
Therefore, in order to solve the above-mentioned drawbacks, attempts have been made to dephosphorize the material before passing through the UF membrane.

例えば生物反応槽にリン(P)を固定化するための凝集
剤を添加したり、あるいは生物反応槽からUF膜に至る
中間で前記の凝集剤を添加する技術が知られている(特
開昭58−128084公報参照)。
For example, there are known techniques in which a flocculant for fixing phosphorus (P) is added to a biological reaction tank, or the flocculant is added intermediately from the biological reaction tank to the UF membrane (Japanese Patent Application Laid-open No. 58-128084).

しかし、この技術においては、生物反応槽内の汚泥濃度
が高いので、リン(P)を固定化させて当該リン(P)
の除去効果を得ようとすると、凝集剤の添加量が大量に
必要になりコスト高を招く欠点があり、また目的とする
リン濃度(例えば法律又は条例等による規制濃度)にす
ることができない欠点があった。 さらに添加された凝
集剤が膜に対してSS負荷を増大させることになり、膜
寿命を縮める欠点がある。
However, in this technology, since the sludge concentration in the biological reaction tank is high, phosphorus (P) is immobilized and the phosphorus (P) is
In order to obtain the removal effect of phosphorus, a large amount of flocculant is required to be added, resulting in high costs.Also, it is not possible to achieve the desired phosphorus concentration (for example, the concentration regulated by law or ordinance). was there. Furthermore, the added flocculant increases the SS load on the membrane, which has the disadvantage of shortening the membrane life.

[発明の目的] 本発明の目的は膜に対するSS負荷を増大させることな
く効果的にリンを除去できるUF膜を用いたし尿処理に
おける脱リン方法を提供することにある。
[Object of the Invention] An object of the present invention is to provide a dephosphorization method in human urine treatment using a UF membrane that can effectively remove phosphorus without increasing the SS load on the membrane.

[問題点を解決するための手段1 本発明者は上記目的を達成すべく鋭意検討を重ねた結果
、本発明を完成するに至った。
[Means for Solving the Problems 1] As a result of extensive studies to achieve the above object, the inventors have completed the present invention.

本発明に係るUF膜を用いたし尿処理における脱リン方
法は、し尿を生物反応槽で処理し、次いでOF膜によっ
て固液分離し汚泥は前記生物反応槽に返送すると共に一
部は余剰汚泥として処理するし尿処理方法において、し
尿を生物反応槽に供給する前に脱リン設備に受け入れ、
該脱リン設備において凝集剤を添加してし尿中の含有リ
ン成分を凝集固体化し、該凝集固体を取り除いた分離液
中に少なくとも生物反応処理に必要な含有リン成分が残
るようにし、次いで該分離水を前記生物反応槽に受け入
れることを特徴とする。
In the dephosphorization method for human waste treatment using the UF membrane according to the present invention, human waste is treated in a biological reaction tank, then solid-liquid separation is performed by an OF membrane, and the sludge is returned to the biological reaction tank, while a part of it is treated as surplus sludge. In the human waste treatment method, the human waste is received in the dephosphorization equipment before being supplied to the biological reaction tank,
In the dephosphorization equipment, a flocculant is added to flocculate and solidify the phosphorus component contained in the human waste, and at least the phosphorus component necessary for biological reaction treatment remains in the separated liquid from which the flocculated solid is removed. It is characterized in that water is received into the biological reaction tank.

[作用] 本発明によれば、脱リン設備において凝集剤を添加する
と、し尿中のssが凝集して凝集汚泥が形成され、この
凝集汚泥に凝集固体化された含有リン成分が付着し一体
化して凝集汚泥が得られ、この汚泥を除去することによ
り、リン成分が除去される。
[Function] According to the present invention, when a flocculant is added in the dephosphorization equipment, the ss in the human waste is flocculated to form flocculated sludge, and the coagulated and solidified phosphorus contained components adhere to this flocculated sludge and are integrated. A flocculated sludge is obtained, and by removing this sludge, the phosphorus component is removed.

また凝集剤の添加量によって凝集反応を制御できるので
、リン成分の除去量を制限し凝集固体を取り除いた分離
液中に少なくとも生物反応処理に必要な含有リン成分が
残るようにすることも可能となる。そしてこのようにリ
ン成分が制御されているので膜処理後のリン成分量も極
めて少なくなり放流可能となる。
Furthermore, since the flocculation reaction can be controlled by the amount of flocculant added, it is also possible to limit the amount of phosphorus component removed so that at least the phosphorus component necessary for biological reaction treatment remains in the separated liquid from which flocculated solids have been removed. Become. Since the phosphorus component is controlled in this way, the amount of phosphorus component after membrane treatment is also extremely small, allowing it to be discharged.

さらに生物反応処理前に脱リン処理設備を設けることに
より、リン以外に有機物質、SSも除去され生物反応処
理の負荷が大幅に軽減される。
Furthermore, by providing a dephosphorization treatment facility before the biological reaction treatment, organic substances and SS are also removed in addition to phosphorus, and the load on the biological reaction treatment is significantly reduced.

ざらに又凝集剤の添加が生物反応処理や膜処理に負荷増
となることもない。
Furthermore, the addition of a flocculant does not increase the load on biological reaction treatment or membrane treatment.

[実施例] 本発明の方法の一実施例を第1図に基づき説明する。[Example] An embodiment of the method of the present invention will be explained based on FIG.

し尿は受入槽1に受け入れられ、し尿中に砂、石等の比
較的大きな夾雑物が含有される場合にはこの受入槽1で
沈降除去される。受入槽l内のし尿は原液ポンプ2によ
り粗目スクリーン3に送られる。粗目スクリーン3は目
開き2mm〜10履履のスクリーンで、このスクリーン
をし尿が通過することにより、し尿中の繊維状物質、ゴ
ム製品、その他の浮遊性夾雑物等の固形物質は除去され
る。
Human waste is received in a receiving tank 1, and if the human waste contains relatively large impurities such as sand and stones, they are sedimented and removed in the receiving tank 1. The human waste in the receiving tank 1 is sent to a coarse screen 3 by a raw solution pump 2. The coarse screen 3 is a screen with an opening of 2 mm to 10 mm, and when the human waste passes through this screen, solid substances such as fibrous substances, rubber products, and other floating impurities in the human waste are removed.

固形物質は脱水機4を用いて脱水され、ケーキは焼却設
備において焼却され、分離水は一次貯留槽5に送られる
。脱水機4としては例えばスクリュープレスを用いるこ
とができる。
The solid material is dewatered using a dehydrator 4, the cake is incinerated in an incinerator, and the separated water is sent to a primary storage tank 5. As the dehydrator 4, for example, a screw press can be used.

粗目スクリーン3を通過したし尿は、−次貯留槽5に送
られ、前記分離水と共にポンプ6により脱リン設備7に
送られる。
The human waste that has passed through the coarse screen 3 is sent to a secondary storage tank 5, and sent to a dephosphorization facility 7 together with the separated water by a pump 6.

脱リン設@7は凝集槽8と凝集剤添加装置9と固液分離
装置10からなる。凝集槽8には、攪拌機11が設けら
れ、攪拌機11は回転速度を可変できるものを用いるこ
とが好ましい。凝集剤添加装置9は凝集剤として好まし
く用いられる高分子凝集剤とポリ硫酸第2鉄を添加する
装置である。
The dephosphorization facility@7 consists of a coagulation tank 8, a flocculant addition device 9, and a solid-liquid separation device 10. The aggregation tank 8 is provided with an agitator 11, and it is preferable to use an agitator 11 whose rotation speed can be varied. The flocculant addition device 9 is a device for adding a polymer flocculant and polyferric sulfate, which are preferably used as flocculants.

12は高分子凝集剤タンクで、該タンク12には攪拌機
13が設けられている。該タンク12に粉末状又は液状
の高分子凝集剤を入れ、水によって希釈して攪拌すれば
所定の濃度(約Q、1〜0.5%)に調製された液状の
凝集剤を得ることができる。14は高分子凝集剤ポンプ
である。
12 is a polymer flocculant tank, and this tank 12 is provided with an agitator 13. If a powdered or liquid polymer flocculant is placed in the tank 12, diluted with water and stirred, a liquid flocculant adjusted to a predetermined concentration (approximately Q, 1 to 0.5%) can be obtained. can. 14 is a polymer flocculant pump.

本発明において用いることができる高分子凝集剤は、限
定されないが、カチオン系高分子凝集剤が好ましく、具
体的には例えば三井すイアナミツド社製re−4804
等が好ましい。
The polymer flocculant that can be used in the present invention is not limited, but a cationic polymer flocculant is preferable, and specifically, for example, re-4804 manufactured by Mitsui Sui Anamido Co., Ltd.
etc. are preferred.

15はポリ硫酸第2鉄タンクで、市販のポリ硫酸第2鉄
(11%液)を受け入れ、希釈又は無希釈のままポンプ
16を用いて所定量添加される。本発明において用いる
ことができる無機凝集剤は、ポリ′8&酸第2鉄以外に
塩化第2鉄等を使用できる。
A ferric polysulfate tank 15 receives commercially available ferric polysulfate (11% liquid) and adds a predetermined amount of it diluted or undiluted using a pump 16. Inorganic flocculants that can be used in the present invention include ferric chloride and the like in addition to poly'8 and ferric acid.

本発明において高分子凝集剤の添加量は、凝集槽8に流
入するdry SS量に対して0.5〜4.0%が好ま
しく、より好ましくは1.0〜2.0%であり、無機凝
集剤の添加量はポリ硫酸第2鉄の場合、5〜50%が好
ましく、より好ましくは10〜30%である。
In the present invention, the amount of polymer flocculant added is preferably 0.5 to 4.0%, more preferably 1.0 to 2.0%, based on the amount of dry SS flowing into the flocculation tank 8. In the case of polyferric sulfate, the amount of the flocculant added is preferably 5 to 50%, more preferably 10 to 30%.

なお、凝集槽8に流入するdry SS量は、凝!V槽
8に後述の余剰汚泥が混入しない場合には、ポンプ6に
よって送液されるし尿中のdry SS量であり、また
余剰汚泥が混入される場合には、し尿中のdry SS
と余剰汚泥中のdry SSの合計量となる。
Note that the amount of dry SS flowing into the coagulation tank 8 is the amount of dry SS flowing into the coagulation tank 8. If excess sludge (described later) does not mix into the V tank 8, this is the amount of dry SS in the night soil sent by the pump 6, and if excess sludge is mixed in, the amount of dry SS in the human waste is the amount
and the total amount of dry SS in the excess sludge.

本発明において凝集槽内では、凝集剤の作用によってし
尿中のリン成分は大部分が固定化され、凝集汚泥中に刊
着状態で存在すると思われるが、生物反応に必要な量だ
け供給する必要があるので、凝集反応を抑制して液中に
必要量のリン成分を残留せしめるようにする。かかる残
留は、凝集剤の添加量等を調整することによって可能で
ある。生物反応に必要な量とは、一般にBOD:P (
リン) =100:0.5〜1程度とされている。し尿
のBol15000ppmの場合、リンは25〜50p
pm程度必要である。
In the present invention, in the coagulation tank, most of the phosphorus components in human waste are fixed by the action of the coagulant, and are thought to exist in the coagulated sludge in a fixed state, but it is necessary to supply only the amount necessary for the biological reaction. Therefore, the aggregation reaction is suppressed and the necessary amount of phosphorus component remains in the liquid. Such residual amount can be achieved by adjusting the amount of coagulant added. The amount required for biological reactions is generally BOD:P (
phosphorus) = 100: about 0.5 to 1. In the case of human waste Bol 15000ppm, phosphorus is 25-50p
About pm is required.

凝集槽8で凝集された汚泥は、図示しないポンプあるい
は自然流下によって固液分離装置10に供給される。固
液分離装置10には、本実施例では微細目スクリーンが
用いられる。微細1.1スクリ−ンとしては、スクリー
ンの目詰まり防止という観点からは0.5■以上の目の
ものが好ましく、また膜の目詰まり防止という観点から
は5mm以下の目のものが好ましい。
The sludge flocculated in the flocculation tank 8 is supplied to the solid-liquid separator 10 by a pump (not shown) or by gravity flow. The solid-liquid separator 10 uses a fine mesh screen in this embodiment. The fine 1.1 screen preferably has a mesh size of 0.5 mm or more from the viewpoint of preventing clogging of the screen, and preferably a mesh of 5 mm or less from the viewpoint of preventing clogging of the membrane.

微細目スクリーン10を通過したし尿は二次貯留槽17
に送られ、通過しない凝集汚泥は脱水機18に送られる
。脱水機18としてスクリュープレスや遠心分m機を用
いることができるが、好ましくはスクリュープレスであ
る。スクリュープレスで脱水されたケーキは焼却設備で
焼却され、濾液は一次貯留槽5にもどされる。
Human waste that has passed through the fine mesh screen 10 is transferred to a secondary storage tank 17
The flocculated sludge that does not pass is sent to the dehydrator 18. Although a screw press or a centrifugal machine can be used as the dehydrator 18, a screw press is preferable. The cake dehydrated in the screw press is incinerated in an incineration facility, and the filtrate is returned to the primary storage tank 5.

脱リンされた二次貯留槽17内のし尿は、ポンプ19に
より生物反応槽20に供給される。生物反応槽20では
、一般的な多段の好気性及び/又は嫌気性による公知の
生物反応が行われ、有機物、窒素成分等が酸化又は還元
により分解除去される。生物反応槽内の構造については
、先に本発明者が提案した特願昭59−267725号
明細書に記載の構造とすることも好ましいが限定されな
い。なおりはブロアーである。
The dephosphorized human waste in the secondary storage tank 17 is supplied to the biological reaction tank 20 by the pump 19. In the biological reaction tank 20, a commonly known multi-stage aerobic and/or anaerobic biological reaction is performed, and organic matter, nitrogen components, etc. are decomposed and removed by oxidation or reduction. Regarding the structure inside the biological reaction tank, it is preferable to use the structure described in Japanese Patent Application No. 59-267725, which was previously proposed by the present inventor, but is not limited thereto. The problem is a blower.

生物反応後の汚泥は、ポンプ21により限外濾過装置2
2に送られ、UF膜により固液分離される。
The sludge after the biological reaction is transferred to an ultrafiltration device 2 by a pump 21.
2, where it is separated into solid and liquid by a UF membrane.

本発明に用いられるUF膜としては、分画分子量100
0〜300万の範囲のものが好ましく、例えば三井石油
化学社製のrUFPlo」、rUFP70」、rUFP
71」等が好ましい。
The UF membrane used in the present invention has a molecular weight cutoff of 100
Those in the range of 0 to 3 million are preferable, such as rUFPlo'', rUFP70'', and rUFP manufactured by Mitsui Petrochemical Co., Ltd.
71'' etc. are preferable.

膜分離された汚泥は、生物反応槽20に返送され、一部
は余剰汚泥として処理される。
The membrane-separated sludge is returned to the biological reaction tank 20, and a portion is treated as surplus sludge.

本発明において余剰汚泥は、凝集槽8に返送することが
好ましく、これにより脱リンと同時に余剰汚泥も処理で
きる。
In the present invention, the excess sludge is preferably returned to the coagulation tank 8, so that the excess sludge can be treated at the same time as dephosphorization.

膜処理された透過水は、活性炭吸着塔23に送られる。The membrane-treated permeated water is sent to the activated carbon adsorption tower 23.

活性炭吸着塔23では有機物質等の高度処理は当然のこ
とながら、し尿特有の脱色が行われる。最終処理水は処
理水ピット24から系外に放流される。
The activated carbon adsorption tower 23 not only performs advanced treatment of organic substances, but also performs decolorization specific to human waste. The final treated water is discharged from the treated water pit 24 to the outside of the system.

[実験例] 実験例 l 下記表1の組成の生し尿300 ranと余剰汚泥10
0mJlを凝集槽に入れて混合して混合原液を作成した
[Experimental Example] Experimental Example l 300 ran of human urine and 10 ran of surplus sludge with the composition shown in Table 1 below
0 mJl was placed in a flocculation tank and mixed to create a mixed stock solution.

表1 注)享:測定せず T−P :全リン濃度(以下同じ) 次いで上記混合原液に下記凝集剤を添加した。Table 1 Note) Kyo: Not measured T-P: Total phosphorus concentration (same below) Next, the following flocculant was added to the above mixed stock solution.

■高分子凝集剤: 商品名二三井サイアナミツド社製rC−480J(カチ
オン系高分子凝集剤) 添加量、 0.2W/V%液を35 m文(dry s
s当たり約1.8%) ■ポリ硫酸第2鉄: 商品名:日銭鉱業社製「ポリ硫酸第2鉄」添加量: 1
00Q+sg(dry ss当たり約23%)なお必要
に応じ苛性ソーダを用いpHを7に調整した。
■Polymer flocculant: Product name: rC-480J (cationic polymer flocculant) manufactured by Nimitsui Cyanamid Co., Ltd. Addition amount: 35 m of 0.2 W/V% liquid (dry s
(approx. 1.8% per s) ■Polyferric sulfate: Product name: Nissen Mining Co., Ltd. "Polyferric sulfate" Addition amount: 1
00Q+sg (approximately 23% based on dry ss) The pH was adjusted to 7 using caustic soda if necessary.

凝集槽で攪拌後、微細目スクリーンで固液分離し、下記
組成の分離水が得られた。
After stirring in a coagulation tank, solid-liquid separation was performed using a fine mesh screen to obtain separated water with the following composition.

(スクリーン分離水の組成) BOD       5500  mg/ ISS  
      250  mg/IT−P       
 41  mg/文上記分離水を生物反応槽に供給して
処理し、UF膜により固液分離した結果、処理水の組成
は下記のようになった。
(Composition of screen separated water) BOD 5500 mg/ISS
250 mg/IT-P
41 mg/liter The above-mentioned separated water was supplied to a biological reaction tank and treated, and solid-liquid separation was performed using a UF membrane. As a result, the composition of the treated water was as follows.

(IJF処理水の組成) BOII        15  mg/立SS   
    trace T−P       O,9mg/立 色変色度    500  度 上記OF処理水を更に活性炭で処理した結果、最終処理
水の組成は下記のようになった。
(Composition of IJF treated water) BOII 15 mg/stand SS
trace T-P O, 9 mg/degree of color change 500 degrees The above OF treated water was further treated with activated carbon, and the composition of the final treated water was as follows.

(活性炭処理水の組成) BOD        9  mg/支SS     
  trace T−P       O,9mg/文 色変色度    6  度 実験例 2 実験例1において凝集剤の添加量を表2のように変化さ
せ、その他は同様に実験を行った。
(Composition of activated carbon treated water) BOD 9 mg/SS
trace T-P O, 9 mg/discoloration degree 6 degrees Experimental Example 2 The experiment was conducted in the same manner as in Experimental Example 1 except that the amount of flocculant added was changed as shown in Table 2.

凝集剤の添加量と処理結果の関係を表2に示す。同表か
ら明らかなように、高分子凝集剤と無機凝集剤を凝集槽
に添加した時には効果的に脱リンがなされていることが
判かる。
Table 2 shows the relationship between the amount of coagulant added and the treatment results. As is clear from the same table, it can be seen that dephosphorization is effectively achieved when a polymer flocculant and an inorganic flocculant are added to the flocculating tank.

比較実験例 l 実験例1において無機凝集剤を添加しない以外は同様に
して実験を行った。
Comparative Experimental Example 1 An experiment was conducted in the same manner as Experimental Example 1 except that no inorganic flocculant was added.

凝集剤の添加量と処理結果の関係を表2に示す、同表か
ら明らかなように、■F処理水のT−Pが45 wrg
/lと高く効果的に脱リンがなされていないことが判か
る。
The relationship between the amount of coagulant added and the treatment results is shown in Table 2. As is clear from the table, the T-P of the
/l, indicating that dephosphorization was not carried out effectively.

比較実験例 2 実験例1において、凝集剤を添加せずに処理を行ったと
ころ、IJF膜処理後の処理水の組成は下記のようにな
り、T−Pは130mg/JLとかなり高く、脱リン効
果はなかった。
Comparative Experimental Example 2 In Experimental Example 1, when the treatment was carried out without adding a flocculant, the composition of the treated water after IJF membrane treatment was as shown below, and the T-P was quite high at 130 mg/JL. There was no phosphorus effect.

(IF処理水の組成) BOo               20   mg
/見SS       trace T−P       130  wrgl1色度   
   600  度 比較実験例 3 実験例1において、高分子凝集剤を添加せず、無機凝集
剤を生物反応槽に添加した。実験例1に比べ大量に添加
したが、実験例1と同様の脱リン効果は得られなかった
。またtlF膜に負荷がかかりすぎて膜の目詰まりが激
しくすぐに膜洗浄が必要となった。
(Composition of IF treated water) BOo 20 mg
/See SS trace T-P 130 wrgl1 chromaticity
600 Degree Comparative Experimental Example 3 In Experimental Example 1, an inorganic flocculant was added to the biological reaction tank without adding a polymer flocculant. Although a larger amount was added than in Experimental Example 1, the same dephosphorizing effect as in Experimental Example 1 could not be obtained. In addition, too much load was placed on the tlF membrane, which caused severe clogging of the membrane, necessitating immediate membrane cleaning.

[発明の効果] 以上の実験例から明らかなように、本発明によれば凝集
剤の少ない添加量で脱リン効果がある。
[Effects of the Invention] As is clear from the above experimental examples, according to the present invention, a dephosphorization effect can be achieved even with a small amount of coagulant added.

また生物反応槽へのSSや有機物の持込みを低減できる
ので生物反応の負荷軽減に寄与し、メインプロセス反応
の効率を上げることができる。さらに膜処理特有の高濃
度汚泥下での処理に適した前処理として効果的に機能す
る脱リンプロセスを提供できる。ざらに又前処理として
脱リン設備を設けるだけでよいので、従来の脱リン処理
と枇べれば設備コストの大幅な軽減となり、プロセス管
理も容易となる。
Furthermore, it is possible to reduce the amount of SS and organic matter brought into the biological reaction tank, contributing to a reduction in the load on biological reactions and increasing the efficiency of the main process reaction. Furthermore, it is possible to provide a dephosphorization process that effectively functions as a pretreatment suitable for treatment under highly concentrated sludge, which is unique to membrane treatment. In addition, since it is only necessary to provide dephosphorization equipment as a pre-treatment, if it can be combined with conventional dephosphorization treatment, the equipment cost will be significantly reduced and process management will be easier.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本発明の方法の一実施例を示す概略説明図であ
る。 l:受入槽 2:ポンプ 3:粗目スクリーン 4:脱水機 5ニ一次貯留槽 6ニポンブ 7:脱リン設備 8:凝集槽 9:凝集剤添加装置 lO:固液分離装置 11;攪拌機 12:高分子凝集剤タンク 13:撹拌機 14:高分子凝集剤ポンプ 15:ポリ硫酸第2鉄タンク 16:ポンプ 17二二次貯留槽 18:脱水機 19:ポンプ 20:生物反応槽 21:ポンプ 22:限外濾過装置 23:活性炭吸着塔 24:処理水ピット
FIG. 1 is a schematic explanatory diagram showing an embodiment of the method of the present invention. 1: Receiving tank 2: Pump 3: Coarse screen 4: Dehydrator 5, primary storage tank 6, pump 7: Dephosphorization equipment 8: Coagulation tank 9: Flocculant addition device 1O: Solid-liquid separation device 11; Stirrer 12: Polymer Coagulant tank 13: Stirrer 14: Polymer coagulant pump 15: Polyferric sulfate tank 16: Pump 17 Secondary storage tank 18: Dehydrator 19: Pump 20: Biological reaction tank 21: Pump 22: Ultra Filtration device 23: Activated carbon adsorption tower 24: Treated water pit

Claims (3)

【特許請求の範囲】[Claims] (1)し尿を生物反応槽で処理し、次いで限外濾過膜に
よって固液分離し汚泥は前記生物反応槽に返送すると共
に一部は余剰汚泥として処理するし尿処理方法において
、し尿を生物反応槽に供給する前に脱リン設備に受け入
れ、該脱リン設備において凝集剤を添加してし尿中の含
有リン成分を凝集固体化し、該凝集固体を取り除いた分
離液中に少なくとも生物反応処理に必要な含有リン成分
が残るようにし、次いで該分離水を前記生物反応槽に受
け入れることを特徴とする限外濾過膜を用いたし尿処理
における脱リン方法。
(1) In a human waste treatment method in which human waste is treated in a biological reaction tank, then solid-liquid separation is performed using an ultrafiltration membrane, and the sludge is returned to the biological reaction tank and a portion is treated as surplus sludge, the human waste is treated in a biological reaction tank. In the dephosphorization equipment, the phosphorus components contained in human waste are coagulated and solidified by adding a flocculant, and the separated liquid from which the flocculated solids are removed contains at least the amount necessary for biological reaction treatment. A dephosphorization method in human urine treatment using an ultrafiltration membrane, characterized in that the phosphorus component remains, and then the separated water is received in the biological reaction tank.
(2)凝集剤が、カチオン系高分子凝集剤とポリ硫酸第
2鉄の組合せであることを特徴とする特許請求の範囲第
1項記載の限外濾過膜を用いたし尿処理における脱リン
方法。
(2) A method for dephosphorization in human urine treatment using an ultrafiltration membrane according to claim 1, wherein the flocculant is a combination of a cationic polymer flocculant and ferric polysulfate. .
(3)脱リン設備を構成する凝集槽に余剰汚泥が混入さ
れることを特徴とする特許請求の範囲第1項または第2
項記載の限外濾過膜を用いたし尿処理における脱リン方
法。
(3) Claims 1 or 2, characterized in that surplus sludge is mixed into a coagulation tank that constitutes the dephosphorization equipment.
A method for dephosphorization in human urine treatment using the ultrafiltration membrane described in Section 3.
JP61236725A 1986-10-03 1986-10-03 Dephosphorization method for night soil treatment by using ultrafilter membrane Pending JPS6391196A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61236725A JPS6391196A (en) 1986-10-03 1986-10-03 Dephosphorization method for night soil treatment by using ultrafilter membrane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61236725A JPS6391196A (en) 1986-10-03 1986-10-03 Dephosphorization method for night soil treatment by using ultrafilter membrane

Publications (1)

Publication Number Publication Date
JPS6391196A true JPS6391196A (en) 1988-04-21

Family

ID=17004857

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61236725A Pending JPS6391196A (en) 1986-10-03 1986-10-03 Dephosphorization method for night soil treatment by using ultrafilter membrane

Country Status (1)

Country Link
JP (1) JPS6391196A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406629B1 (en) 1999-07-20 2002-06-18 Zenon Environmental Inc. Biological process for removing phosphorous involving a membrane filter
US6485645B1 (en) 1999-07-20 2002-11-26 Zenon Environmental Inc Biological process for removing phosphorus involving a membrane filter
US6723245B1 (en) 2002-01-04 2004-04-20 Nalco Company Method of using water soluble cationic polymers in membrane biological reactors
US8017014B2 (en) 2005-06-01 2011-09-13 Nalco Company Method for improving flux in a membrane bioreactor
US8889008B2 (en) 2008-05-02 2014-11-18 Nalco Company Method of conditioning a mixed liquor containing nonionic polysaccharides and/or nonionic organic molecules

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6369598A (en) * 1986-09-11 1988-03-29 Ebara Infilco Co Ltd Treatment of organic sewage containing phosphorus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6369598A (en) * 1986-09-11 1988-03-29 Ebara Infilco Co Ltd Treatment of organic sewage containing phosphorus

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406629B1 (en) 1999-07-20 2002-06-18 Zenon Environmental Inc. Biological process for removing phosphorous involving a membrane filter
US6485645B1 (en) 1999-07-20 2002-11-26 Zenon Environmental Inc Biological process for removing phosphorus involving a membrane filter
US6723245B1 (en) 2002-01-04 2004-04-20 Nalco Company Method of using water soluble cationic polymers in membrane biological reactors
US6926832B2 (en) 2002-01-04 2005-08-09 Nalco Company Method of using water soluble polymers in a membrane biological reactor
US8017014B2 (en) 2005-06-01 2011-09-13 Nalco Company Method for improving flux in a membrane bioreactor
US8889008B2 (en) 2008-05-02 2014-11-18 Nalco Company Method of conditioning a mixed liquor containing nonionic polysaccharides and/or nonionic organic molecules

Similar Documents

Publication Publication Date Title
JP3879136B2 (en) Dephosphorization equipment
JP4839645B2 (en) Method and apparatus for treating human waste sewage
JPS6391196A (en) Dephosphorization method for night soil treatment by using ultrafilter membrane
JP2010000476A (en) Organic wastewater treatment method and apparatus
JPH0124558B2 (en)
JP3496773B2 (en) Advanced treatment method and apparatus for organic wastewater
JP3339352B2 (en) Sludge treatment method
JPS6320600B2 (en)
JPH1052697A (en) Method for reduction of organic sludge
JPS58139798A (en) Treatment of organic waste liquid
JPH0535039B2 (en)
CN109205916A (en) The processing method of wash water is sprayed in production process of activated carbon
JPH0339760B2 (en)
JPS596986A (en) Treatment of night soil-type filthy water
CZ282995B6 (en) Process of treating waste water, particularly of car wash waste water
US6117314A (en) Apparatus for removing metal compounds from waste material
JPH0419920B2 (en)
JPH0513719B2 (en)
JPS58112099A (en) Purification of organic waste water
JPH06269799A (en) Treatment of sludge
JPH0582279B2 (en)
JPH0741275B2 (en) Sludge treatment method and equipment for organic wastewater
JPS63221900A (en) Treatment of excretion-based sewage
JPH0217240B2 (en)
JPS62110796A (en) Treatment of night soil